Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06793033Not ApplicableRecruiting

A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support

Role: lead

NCT05444049Not ApplicableCompleted

NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

Role: lead

NCT05146661Not ApplicableCompleted

NEURESCUE Device as an Adjunct to Cardiac Arrest

Role: lead

NCT04491903Not ApplicableWithdrawn

REBOA for Out-of-hospital Cardiac Arrest

Role: lead

All 4 trials loaded